Cerebral venous thrombosis and activated protein C resistance.

Suppr

超能文献

作者信息

Sánchez del Rio M, Gómez-Tortosa E, Outeriño J

出版信息

J Neurol. 1996 Oct;243(10):727-8. doi: 10.1007/BF00873981.

DOI:10.1007/BF00873981

PMID:8923308

Abstract

摘要

相似文献

Cerebral venous thrombosis and activated protein C resistance.

J Neurol. 1996 Oct;243(10):727-8. doi: 10.1007/BF00873981.

[Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].

Dtsch Med Wochenschr. 1998 Feb 6;123(6):137-9. doi: 10.1055/s-2007-1023917.

Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation.

Stroke. 1996 Oct;27(10):1719-20. doi: 10.1161/01.str.27.10.1719.

Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden).一名患有因子V突变（FV莱顿突变）的新生儿出现双侧肾静脉血栓形成和静脉窦血栓形成。

J Pediatr. 1998 Jan;132(1):159-61. doi: 10.1016/s0022-3476(98)70504-9.

Resistance to activated protein C: a major cause of inherited thrombophilia.对活化蛋白C的抵抗：遗传性血栓形成倾向的主要原因。

Clin Lab Sci. 1997 Jul-Aug;10(4):219-22.

[Activated protein C resistance: role in venous and arterial thrombosis].[活化蛋白C抵抗：在静脉和动脉血栓形成中的作用]

Arch Mal Coeur Vaiss. 1996 Jun;89(6):741-5.

Activated protein C resistance as a "new" cause of deep venous thrombosis in aviators.活化蛋白C抵抗作为飞行员深静脉血栓形成的“新”原因。

Aviat Space Environ Med. 1997 Jul;68(7):606-8.

Coagulation factor V gene mutation associated with activated protein C resistance leading to recurrent thrombosis, leg ulcers, and lymphedema: successful treatment with intermittent compression.

J Am Acad Dermatol. 1996 Aug;35(2 Pt 2):306-9. doi: 10.1016/s0190-9622(96)90655-6.

Testing for resistance to activated protein C factor V R506Q.检测活化蛋白C因子V R506Q的抗性。

Arch Pathol Lab Med. 1998 Dec;122(12):1046.

Cerebral haemorrhagic infarction in young patients with hereditary protein C deficiency: evidence for "spontaneous" cerebral venous thrombosis.

Br Med J (Clin Res Ed). 1985 Feb 2;290(6465):350-2. doi: 10.1136/bmj.290.6465.350.

引用本文的文献

Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study.凝血因子V莱顿突变、凝血因子V剑桥突变、凝血因子II GA20210突变及亚甲基四氢叶酸还原酶与脑静脉窦血栓形成的病例对照研究

J Res Med Sci. 2015 Jun;20(6):554-62. doi: 10.4103/1735-1995.165956.

本文引用的文献

Factor V gene mutation is a risk factor for cerebral venous thrombosis.凝血因子V基因突变是脑静脉血栓形成的一个危险因素。

Thromb Haemost. 1996 Mar;75(3):393-4.

Mutation in blood coagulation factor V associated with resistance to activated protein C.凝血因子V突变与活化蛋白C抵抗相关。

Nature. 1994 May 5;369(6475):64-7. doi: 10.1038/369064a0.

Human genetics. Bad blood by mutation.人类遗传学。因突变导致的不良血统。

Nature. 1994 May 5;369(6475):14-5. doi: 10.1038/369014a0.

Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.遗传性活化蛋白C抵抗现象可通过被发现具有因子V特性的抗凝辅因子活性来纠正。

Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1396-400. doi: 10.1073/pnas.91.4.1396.

[Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations].[静脉血栓栓塞并发症中对活化蛋白C的抵抗。发生率及临床表现]

Presse Med. 1995 Jan 28;24(4):209-12.

Activated protein C resistance in cases of cerebral infarction.脑梗死病例中的活化蛋白C抵抗

Lancet. 1995 Mar 25;345(8952):795. doi: 10.1016/s0140-6736(95)90674-6.

High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance).凝血因子V莱顿纯合子（活化蛋白C抵抗）患者发生血栓形成的风险很高。

Blood. 1995 Mar 15;85(6):1504-8.

Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance.心肌梗死、凝血因子V的精氨酸506突变为谷氨酰胺以及活化蛋白C抵抗。

Lancet. 1995 Feb 4;345(8945):321.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验